<?xml version="1.0" encoding="UTF-8"?>
<PAPER>

<BODY>
<DIV><P>
</P>
<P>[0001] PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING COLOSTRUM, <ne id="WO2007000651.HC.class-names.1" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">TOCOPHEROLS</ne>, <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.1" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">ZINC OXIDE</ne> AND <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.1" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">HYALURONIC ACID</ne>
FIELD OF INVENTION
This invention relates to pharmaceutical and cosmetic compositions containing colostrum, <ne id="WO2007000651.HC.class-names.2" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">tocopherols</ne>, <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.2" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">zinc oxide</ne> and <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.2" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">hyaluronic acid</ne> for the treatment of skin disorders, sores, burns, diabetic lesions, rashes and the like. PRIOR ART
Colostrum is known to have properties useful for the treatment of skin diseases such  dermatitis, irritations, dyskeratosis and the like (see, for example, IT 1265252 and IT 1264637).
The <ne id="WO2007000651.HC.class-names.3" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">tocopherols</ne> are known for their cell <ne type="ONT" id="WO2007000651.HC.class-names.12" epochem-id="EPOCHEM:NEW:CLASS:840" name="antioxidant" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidant</ne> action. <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.3" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">Zinc oxide</ne> is widely used in dermatological formulations for its protective, <ne type="ONT" id="WO2007000651.HC.class-names.10" epochem-id="EPOCHEM:NEW:CLASS:6" name="astringent" comment="" chebi-id="WO2007000651:157583" relevant="false">astringent</ne> and <ne type="ONT" id="WO2007000651.HC.class-names.11" epochem-id="EPOCHEM:NEW:CLASS:7" name="antiseptic" comment="" chebi-id="WO2007000651:309041" relevant="false">antiseptic</ne> activity.
<ne type="CHEMICAL" id="WO2007000651.HC.substance-names.3" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">Hyaluronic acid</ne> is a natural <ne id="WO2007000651.HC.class-names.9" epochem-id="EPOCHEM:NEW:CLASS:5" name="mucopolysaccharide polymer" comment="" chebi-id="WO2007000651:123705" relevant="false" type="CLASS">mucopolysaccharide polymer</ne> with high viscosity and a molecular weight ranging between 50,000 and 8xlO&lt;6&gt;, obtainable from animal tissues or micro-organisms. <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.4" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">Hyaluronic acid</ne> and its salts have long been used in pharmaceutical and cosmetic formulations for their viscosity-controlling, healing, reparatory and protective properties.  OF THE INVENTION
This invention relates to pharmaceutical and cosmetic compositions containing: a) colostrum; b) <ne id="WO2007000651.HC.class-names.4" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">tocopherols</ne>; c) <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.4" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">zinc oxide</ne>; d) <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.5" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">hyaluronic acid</ne> or its salts; for the treatment of dermatological disorders, sores, burns, diabetic lesions, rashes and the like.
The compositions according to the invention have an anti-irritant, emollient, , decongestant, healing, sun filtering and sebum- normalising action, and repair the damage caused by sunlight, physical and chemical agents and atmospheric agents.
The compositions according to the invention are therefore useful for the treatment of  diseases such as seborrhoeic dermatitis and alopecia, sores, burns, rashes, diabetic lesions and the like.
It has now surprisingly been found that a combination of the constituents of the compositions according to the invention produces far superior effects to the separate administration of each individual component, probably due to a synergic action between said constituents.
According to the invention, the colostrum will be obtained from mammals such as cattle, horses and sheep. According to a preferred aspect of the invention, the colostrum will be of bovine origin.
According to a preferred aspect of the invention, the <ne id="WO2007000651.HC.class-names.5" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">tocopherols</ne> will be chosen from <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.11" epochem-id="EPOCHEM:NEW:COMPOUND:4" name="vitamin E" comment="" chebi-id="CHEBI:33234" relevant="false">vitamin E</ne> and <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.9" epochem-id="EPOCHEM:NEW:COMPOUND:3" name="vitamin E acetate" comment="" chebi-id="WO2007000651:938320" relevant="false">vitamin E acetate</ne>.
According to a preferred aspect of the invention, the colostrum content of the compositions according to the invention will range between approximately 10 and 20% in weight of the composition.
According to a preferred aspect of the invention, the <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.22" epochem-id="EPOCHEM:NEW:COMPOUND:10" name="tocopherol" comment="" chebi-id="CHEBI:27013" relevant="false">tocopherol</ne> content of the compositions according to the invention will range between approximately 0.1 and 2% in weight of the composition.
According to a preferred aspect of the invention, the <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.5" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">zinc oxide</ne> content of the compositions according to the invention will range between approximately 10 and 20% in weight of the composition.
<ne type="CHEMICAL" id="WO2007000651.HC.substance-names.6" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">Hyaluronic acid</ne> or its salts, preferably <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.12" epochem-id="EPOCHEM:NEW:SUBSTANCE:8" name="sodium hyaluronan" comment="" chebi-id="WO2007000651:431166" relevant="false">sodium hyaluronan</ne>, will be present in concentrations ranging between approximately 0.5 and 0.8% in weight. The compositions according to the invention can be formulated in a way suitable for topical administration, and will be prepared according to conventional methods well known in pharmaceutical technology, such as those described in "Remington's Pharmaceutical Handbook", Mack Publishing Co., N. Y., USA, using excipients and diluents conventionally employed in the preparation of pharmaceutical and cosmetic formulations, such as <ne type="ONT" id="WO2007000651.HC.class-names.17" epochem-id="EPOCHEM:NEW:CLASS:1069" name="thickeners" comment="" chebi-id="WO2007000651:310686" relevant="false">thickeners</ne>, <ne type="ONT" id="WO2007000651.HC.class-names.16" epochem-id="EPOCHEM:NEW:CLASS:1038" name="emulsifiers" comment="" chebi-id="WO2007000651:846007" relevant="false">emulsifiers</ne>, <ne type="ONT" id="WO2007000651.HC.class-names.13" epochem-id="EPOCHEM:NEW:CLASS:845" name="detergents" comment="" chebi-id="CHEBI:27780" relevant="false">detergents</ne>, <ne type="ONT" id="WO2007000651.HC.class-names.14" epochem-id="EPOCHEM:NEW:CLASS:846" name="surfactants" comment="" chebi-id="CHEBI:35195" relevant="false">surfactants</ne>, <ne type="ONT" id="WO2007000651.HC.class-names.18" epochem-id="EPOCHEM:NEW:CLASS:420" name="preservatives" comment="" chebi-id="WO2007000651:120429" relevant="false">preservatives</ne>, <ne type="ONT" id="WO2007000651.HC.class-names.15" epochem-id="EPOCHEM:NEW:CLASS:847" name="perfumes" comment="" chebi-id="CHEBI:48318" relevant="false">perfumes</ne>, etc..
Examples of formulations according to the invention are ointments, creams, lotions, gels, tonic lotions, emulsions, foams, milks, dusting powders, occlusive plasters with Hydrogel, and the like.
Moreover, the compositions according to the invention may contain other active constituents with a complementary or otherwise useful activity, such as anti-inflammatory, antibacterial, moisturising, emollient, healing and repair agents, and plant extracts such as Edera helix, Centella asiatica, borage, calendula, sage, rosemary, vegetable oils, pineapple, seaweed, papaya, bilberry, sweet chestnut, red vine, mallow, elastin, collagen, witch hazel, wheatgerm, carrot, green clay, thyme, propolis, etc..
The methods and frequency of application will obviously depend on the type of formulation and the required effect, but broadly speaking could be 1 to 3 times a day or more.
The following are some examples of compositions according to the invention.
EXAMPLE 1
Body cream
INGREDIENTS percentages in weight
Bovine colostrum 15%
<ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.17" epochem-id="EPOCHEM:NEW:COMPOUND:7" name="Tocopherol acetate" comment="" chebi-id="WO2007000651:702702" relevant="false">Tocopherol acetate</ne> 1%
<ne type="FORMULA" id="WO2007000651.HC.formula-names.1" epochem-id="EPOCHEM:NEW:FORMULA:1" name="ZnO" comment="" chebi-id="CHEBI:36560" relevant="false">ZnO</ne> 10% <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.7" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">Hyaluronic acid</ne> (<ne type="CHEMICAL" id="WO2007000651.HC.substance-names.13" epochem-id="EPOCHEM:NEW:SUBSTANCE:8" name="sodium hyaluronan" comment="" chebi-id="WO2007000651:431166" relevant="false">sodium hyaluronan</ne>) 0.6%
Wheatgerm oil 10%
Karite butter 3%
<ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.15" epochem-id="EPOCHEM:NEW:COMPOUND:5" name="Sodium lactate" comment="" chebi-id="WO2007000651:567406" relevant="false">Sodium lactate</ne> 2% <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.16" epochem-id="EPOCHEM:NEW:COMPOUND:6" name="Glycerol" comment="" chebi-id="CHEBI:17754" relevant="false">Glycerol</ne> 2%
<ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.20" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> q.b.
EXAMPLE 2
Dermatological cream for the treatment of bedsores, diabetes sores, rashes and burns INGREDIENTS percentages in weight
Bovine colostrum 20%
<ne type="FORMULA" id="WO2007000651.HC.formula-names.2" epochem-id="EPOCHEM:NEW:FORMULA:1" name="ZnO" comment="" chebi-id="CHEBI:36560" relevant="false">ZnO</ne> 15%
<ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.18" epochem-id="EPOCHEM:NEW:COMPOUND:7" name="Tocopherol acetate" comment="" chebi-id="WO2007000651:702702" relevant="false">Tocopherol acetate</ne> 2%
<ne type="CHEMICAL" id="WO2007000651.HC.substance-names.8" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">Hyaluronic acid</ne> (<ne type="CHEMICAL" id="WO2007000651.HC.substance-names.14" epochem-id="EPOCHEM:NEW:SUBSTANCE:8" name="sodium hyaluronan" comment="" chebi-id="WO2007000651:431166" relevant="false">sodium hyaluronan</ne>) 0.8% Beeswax 10%
Wheatgerm oil 10%
<ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.19" epochem-id="EPOCHEM:NEW:COMPOUND:8" name="Panthenol" comment="" chebi-id="WO2007000651:768688" relevant="false">Panthenol</ne> 3%
<ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.21" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> q.b.
</P></DIV>
<DIV><P>
CLAIMS
</P>
<P>1. Topical pharmaceutical and cosmetic compositions containing: a) colostrum; b) <ne id="WO2007000651.HC.class-names.6" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">tocopherols</ne>; c) <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.6" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">zinc oxide</ne>; d) <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.9" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">hyaluronic acid</ne> or its salts.
</P>
<P>2. Compositions as claimed in claim 1, containing colostrum originating from mammals chosen from among cattle, horses and sheep. 3. Compositions as claimed in claim 2, wherein the colostrum is of bovine origin.
</P>
<P>4. Compositions as claimed in claim 1, wherein the <ne id="WO2007000651.HC.class-names.7" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">tocopherols</ne> are chosen from among <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.13" epochem-id="EPOCHEM:NEW:COMPOUND:4" name="vitamin E" comment="" chebi-id="CHEBI:33234" relevant="false">vitamin E</ne> and <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.10" epochem-id="EPOCHEM:NEW:COMPOUND:3" name="vitamin E acetate" comment="" chebi-id="WO2007000651:938320" relevant="false">vitamin E acetate</ne>.
</P>
<P>5. Compositions as claimed in claims 1-3, wherein the colostrum content ranges between 10 and 20% in weight of the composition.
</P>
<P>6. Compositions as claimed in the preceding claims, wherein the <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.25" epochem-id="EPOCHEM:NEW:COMPOUND:10" name="tocopherol" comment="" chebi-id="CHEBI:27013" relevant="false">tocopherol</ne> content ranges between 0.1 and 2% of the weight of the composition.
</P>
<P>7. Compositions as claimed in the preceding claims, wherein the <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.7" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">zinc oxide</ne> content ranges between 10 and 20% of the weight of the composition.
</P>
<P>8. Compositions as claimed in the preceding claims, wherein the content of <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.10" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">hyaluronic acid</ne> or its salts ranges between 0.5 and 0.8% of the weight of the composition.
</P>
<P>9. Compositions as claimed in the preceding claims, in the form of ointments, creams, lotions, gels, tonic lotions, emulsions, foams, milks, dusting powders, occlusive plasters, and occlusive plasters with Hydrogel.
</P>
<P>10. Use of a combination of: a) colostrum; b) <ne id="WO2007000651.HC.class-names.8" epochem-id="EPOCHEM:NEW:CLASS:4" name="tocopherols" comment="" chebi-id="CHEBI:27013" relevant="false" type="CLASS">tocopherols</ne>; c) <ne type="CHEMICAL" id="WO2007000651.HC.chemical-names.8" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">zinc oxide</ne>; d) <ne type="CHEMICAL" id="WO2007000651.HC.substance-names.11" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">hyaluronic acid</ne> or its salts; to prepare compositions for the treatment of skin disorders, sores, burns, diabetic lesions and rashes.
</P></DIV>
</BODY>
</PAPER>
